ASX:CAU

Cronos Australia Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume23,416 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive CAU News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Australia and its competitors with MarketBeat's FREE daily newsletter.

About Cronos Australia

Cronos Australia Limited operates as a medicinal cannabis company in Australia and Asia. The company operates through Medicinal Cannabis and Clinics segments. It distributes PEACE NATURALS brand medicinal cannabis products; develops and sells medicinal cannabis products; and operates medicinal cannabis clinics. The company was incorporated in 2018 and is headquartered in South Yarra, Australia.

Health Check: How Prudently Does Cronos Australia (ASX:CAU) Use Debt?
January 1, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Drug Manufacturers—Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:CAU
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.cronosaustralia.com
Phone: 1300 799 491
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1.69 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 0.79
Book Value: A$0.07 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 25.63
Current Ratio: 3.66
Quick Ratio: 3.08

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cronos Australia.

5.0 Community Rank

Outperform Votes
Cronos Australia has received 1 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Australia has received 0 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Australia has received 100.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Australia and other stocks. Vote “Outperform” if you believe CAU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CAU will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Australia does not currently pay a dividend.
Dividend Growth
Cronos Australia does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Australia insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cronos Australia (ASX:CAU) Frequently Asked Questions

What stocks does MarketBeat like better than Cronos Australia?: Wall Street analysts have given Cronos Australia a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cronos Australia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are Cronos Australia's key executives?: Cronos Australia's management team includes the following people:
Mr. Rodney Damon Cocks, CEO & Exec. Director
Mr. Thomas Godfrey Howitt, CFO & Company Sec. (Age 57, Pay $393.28k)
Who are some of Cronos Australia's key competitors?: Some companies that are related to Cronos Australia include 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), AFT Pharmaceuticals (AFP), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Ascend Wellness (AWWH), Australian Primary Hemp (APH), Ayr Wellness (AYRWF) and BellRock Brands (DXBRF).
View all of CAU's competitors.
What is Cronos Australia's stock symbol?: Cronos Australia trades on the ASX under the ticker symbol "CAU."
How much money does Cronos Australia make?: Cronos Australia has a market capitalization of $0.00 and generates $1.69 million in revenue each year.
What is Cronos Australia's official website?: The official website for Cronos Australia is www.cronosaustralia.com.
How can I contact Cronos Australia?: The company can be reached via phone at 1300 799 491.

This page was last updated on 10/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.